CVE-2025-64642 — HIGH (8.0)

Q: How severe is CVE-2025-64642?

CVE-2025-64642 has been rated HIGH with a CVSS base score of 8.0/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2025-64642?

Check the references section above for vendor advisories and patch information. Affected products include: Mirion Biodose\/Nmis.

Vulnerability Description

NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.

CVSS Score

8.0

HIGH

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H

Attack Vector

LOCAL

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

NONE

Scope

UNCHANGED

Confidentiality

LOW

Integrity

HIGH

Availability

HIGH

Affected Products

Vendor	Product	Versions
Mirion	Biodose\/Nmis	< 23.0

Related Weaknesses (CWE)

CWE-732

References

https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01Third Party Advisory

FAQ

What is CVE-2025-64642?

CVE-2025-64642 is a vulnerability with a CVSS score of 8.0 (HIGH). NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modi...

How severe is CVE-2025-64642?

CVE-2025-64642 has been rated HIGH with a CVSS base score of 8.0/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2025-64642?

Check the references section above for vendor advisories and patch information. Affected products include: Mirion Biodose\/Nmis.